Compliance

  • November 19, 2025

    GTCR Wants FTC's In-House Merge Case Withdrawn Too

    GTCR BC Holdings LLC wants the Federal Trade Commission to rethink its in-house challenge to a medical coatings supplier merger after an Illinois federal judge refused a temporary block and the FTC opted not to appeal that rejection.

  • November 19, 2025

    8th Circ. Hears PBMs' Bid To Pause FTC Insulin Pricing Case

    An Eighth Circuit panel had only a handful of questions on Wednesday for the pharmacy benefit managers accused of inflating insulin prices, though one of the judges expressed skepticism about pausing the Federal Trade Commission's in-house enforcement action on constitutional grounds.

  • November 19, 2025

    Whole Foods' $1M Asbestos Suit Survives Dismissal Bid

    Whole Foods can proceed with its $1 million lawsuit over construction work that freed asbestos and forced a store to close temporarily, after a North Carolina Business Court judge ruled the grocer alleged enough to support contract breach claims against a plaza owner and sublessor.

  • November 19, 2025

    Gilead Sciences' GC Will Leave Co. Next Month

    Gilead Sciences Inc. announced Wednesday that Deborah H. Telman will no longer serve as its executive vice president for corporate affairs and general counsel as of Dec. 5, 2025.

  • November 19, 2025

    Eco Orgs. Ask 2nd Circ. To Undo NY, NJ Pipeline Project Nods

    Environmental groups have sued New York and New Jersey environmental regulators over their issuance of Clean Water Act permits for a controversial Williams Cos. pipeline upgrade after previously denying the permits over pollution concerns.

  • November 19, 2025

    Tax Court Substance Ruling Offers Silver Lining For Taxpayers

    Even though the U.S. Tax Court upheld stiff penalties under the economic substance doctrine against an eye doctor's microcaptive arrangements, the opinion generally favored taxpayers by clarifying that the IRS faces limits on when it can invoke the doctrine to audit transactions.

  • November 19, 2025

    Pillsbury Asks 2nd Circ. To Guard $4M Client Fee From SEC

    Pillsbury Winthrop Shaw Pittman LLP on Wednesday urged the Second Circuit to allow it to keep a $4 million advance payment retainer from the since-convicted former CEO of a bankrupt cybersecurity company, but the law firm conceded it should have clarified its rights after the government sought an asset freeze.

  • November 19, 2025

    Doctor, Husband Admit $16M Healthcare Fraud, Tax Evasion

    A physician and her husband admitted to committing more than $16 million in healthcare fraud and tax evasion as part of a scheme that injected sick patients with the wrong medications or dosages, according to their plea agreements in Alaska federal court.

  • November 19, 2025

    Tribes Challenge Oklahoma Over Hunting, Fishing Rights

    A trio of Oklahoma Indigenous nations are asking a federal district court to declare that they have the right to hunt and fish on their reservation lands, arguing that the state is violating their treaty rights and inherent sovereign authority by prosecuting their members.

  • November 19, 2025

    Air Force Asks Justices To Nix Guam Munitions Disposal Suit

    The U.S. Air Force is urging the Supreme Court to sink a Guam community group's challenge to the branch's request for a renewed permit to explode expired munitions on the island.

  • November 19, 2025

    Pfizer To Pay $41.5M To Settle Adulterated ADHD Drug Claims

    Pfizer Inc. and Tris Pharma Inc. agreed Wednesday to cough up $41.5 million to settle claims brought by Texas that it gave adulterated ADHD drugs to children, ending a lawsuit alleging the companies violated a state healthcare fraud law.

  • November 19, 2025

    EU Tax Compliance Rules Raise €6.8B Annually, EC Finds

    The European Union's directive for administrative cooperation in taxation, known as DAC, has helped tax authorities generate €6.8 billion ($7.8 billion) a year in extra revenue, the European Commission said in a report Wednesday.

  • November 19, 2025

    Trump's Global Tariffs Curtailed Trade, Data Shows

    U.S. imports dropped by 5.1% in August, the month when many of President Donald Trump's global tariffs took effect, according to data released Wednesday by the Bureau of Economic Analysis.

  • November 19, 2025

    Trump's New Pick For CFPB Director Is OMB Energy Official

    President Donald Trump has tapped an energy official at the Office of Management and Budget to become permanent director of the Consumer Financial Protection Bureau, a key regulator whose future remains in doubt after months of turmoil and dwindling finances.

  • November 19, 2025

    Trump Taps Norton Rose Atty To Be EEOC General Counsel

    President Donald Trump has nominated Norton Rose Fulbright's global labor and employment head to serve a four-year term as general counsel of the U.S. Equal Employment Opportunity Commission.

  • November 18, 2025

    Pillsbury Winthrop Latest Firm Targeted By Data Breach Suit

    Pillsbury Winthrop Shaw Pittman LLP on Tuesday was hit with a proposed class action stemming from a data breach the firm says happened in April, adding to the growing litigation firms are facing in the aftermath of cyberattacks.

  • November 18, 2025

    Sick With Cancer, Jack Abramoff Avoids Jail In Crypto Fraud

    Disgraced Washington, D.C., lobbyist Jack Abramoff avoided a second stint in prison when a California federal judge sentenced him Tuesday to probation for his role in a cryptocurrency fraud, citing his cooperation with law enforcement and his stage-four cancer.

  • November 18, 2025

    Health Co. Execs Convicted In $100M Adderall Sales Scheme

    A San Francisco federal jury weighing a first-of-its-kind case on Tuesday convicted two digital healthcare company executives of scheming to sell Adderall through deceptive advertising, allegedly bringing in $100 million in illicit profits.

  • November 18, 2025

    Ex-FDA Chief Accuses J&J Of Hiding Talc Risks For 50 Years

    A former head of the U.S. Food and Drug Administration spent a contentious day under cross-examination Tuesday in a Los Angeles bellwether trial over claims that Johnson & Johnson's talc products caused two women's ovarian cancer, accusing the company of hiding the products' health risks for over 50 years.

  • November 18, 2025

    Buyers Ask To Add 'Hawk Tuah' Influencer To Token Suit

    Buyers of the "Hawk Tuah" themed-meme coin want to expand their securities suit with new claims and defendants, including naming the social media star behind the viral phrase, Haliey Welch, as well as her managers.

  • November 18, 2025

    Feds Grill NY Gov. Aide's Mom In Pursuit Of FARA Money Trail

    Federal prosecutors on Tuesday turned their focus to tracing the proceeds from a purported scheme by a former top New York state government staffer to secretly further the interests of the People's Republic of China, calling the defendant's own mother to the stand over a bank account alleged to have been used to move criminal funds.

  • November 18, 2025

    Crypto Scammer Admits Role In $263M RICO Conspiracy

    An eighth defendant has pled guilty to participating in a scam ring accused of stealing at least $263 million in cryptocurrency from victims across the U.S. to spend on high-priced goods, prosecutors said Tuesday.

  • November 18, 2025

    Fed Pushes To Shift Oversight Focus In Examiner Guidance

    The Federal Reserve shared new internal guidance Tuesday that directs its examiners to concentrate on material financial risks to banks and not get "distracted" by process concerns, deepening a policy shift that is drawing sharp rebuke from Fed Gov. Michael Barr.

  • November 18, 2025

    CFPB's Gradler Takes Deputy Post Amid Agency Uncertainty

    Geof Gradler, a former industry lobbyist who recently joined the Consumer Financial Protection Bureau's front office, said that he is taking over as the agency's deputy director, a job that positions him as a potential successor to acting director Russell Vought.

  • November 18, 2025

    Ex-PetIQ Exec Cops To Insider Trading Ahead Of Acquisition

    A former executive for Idaho-based PetIQ has pled guilty to insider trading after using another person's brokerage account to purchase stock in his company ahead of its planned acquisition in 2024, court filings show.

Expert Analysis

  • Federal Acquisition Rules Get Measured Makeover

    Author Photo

    The Trump administration's promised overhaul of the Federal Acquisition Regulation is not a revolution in rules, but a meaningful recalibration of procurement practice that gives contracting officers more space to think, to tailor and to try, say attorneys at Mayer Brown.

  • 2nd Circ. Peloton Ruling Emphasizes Disclosure Context

    Author Photo

    The Second Circuit’s recent decision to revive shareholders’ suit alleging that Peloton made materially misleading statements makes clear that public companies must continually review risk disclosures to determine if previous hypotheticals have materialized, say attorneys at Baker Botts.

  • Series

    Mindfulness Meditation Makes Me A Better Lawyer

    Author Photo

    Mindful meditation enables me to drop the ego, and in helping me to keep sight of what’s important, permits me to learn from the other side and become a reliable counselor, says Roy Wyman at Bass Berry.

  • Lessons From 7th Circ. Decision Affirming $183M FCA Verdict

    Author Photo

    The Seventh Circuit's decision to uphold a $183 million False Claims Act award against Eli Lilly engages substantively with recurring materiality and scienter questions and provides insights into appellate review of complex trial court judgments, say Ellen London at London & Naor, Li Yu at Bernstein Litowitz and Kimberly Friday at Osborn Maledon.

  • HSR Data Shows Most Deals Exit Antitrust Review Unscathed

    Author Photo

    Merger activity is up, enforcement is down and the vast majority of deals are emerging from U.S. federal antitrust review in one piece, new 2024 fiscal-year Hart-Scott-Rodino data shows, meaning companies should not shy away from deals based on a perception that recent antitrust enforcement has been unusually aggressive, says Amanda Wait at Michael Best.

  • AI Litigation Tools Can Enhance Case Assessment, Strategy

    Author Photo

    Civil litigators can use artificial intelligence tools to strengthen case assessment and aid in early strategy development, as long as they address the risks and ethical considerations that accompany these uses, say attorneys at Barnes & Thornburg.

  • Post-Genius Landscape Reveals Technical Stablecoin Hurdles

    Author Photo

    The Genius Act's implementation has revealed challenges for mass stablecoin adoption, but there are several factors that stablecoin issuers can use to differentiate themselves and secure market share, including interest rate, liquidity, and safety and security, say attorneys at Olshan Frome.

  • How Employers Should Reshape AI Use As Laws Evolve

    Author Photo

    As laws and regulations on the use of artificial intelligence in employment evolve, organizations can maximize the innovative benefits of workplace AI tools and mitigate their risks by following a few key strategies, including designing tools for auditability and piloting them in states with flexible rules, say attorneys at Cooley.

  • Attys Beware: Generative AI Can Also Hallucinate Metadata

    Author Photo

    In addition to the well-known problem of AI-generated hallucinations in legal documents, AI tools can also hallucinate metadata — threatening the integrity of discovery, the reliability of evidence and the ability to definitively identify the provenance of electronic documents, say attorneys at Law & Forensics.

  • How 9th Circ. Ruling Deepens SEC Disgorgement Circuit Split

    Author Photo

    The Ninth Circuit's recent decision in U.S. Securities and Exchange Commission v. Sripetch creates opposing disgorgement rules in the two circuits where the SEC brings a large proportion of enforcement actions — the Second and Ninth — and increases the likelihood that the U.S. Supreme Court will step in, say attorneys at Cahill Gordon.

  • What May Be Ahead In Debanking Enforcement

    Author Photo

    President Donald Trump's executive order on politicized or unlawful debanking has spurred a flurry of activity by the federal banking regulators, so banks should expect debanking-related complaints submitted by consumers to increase, and for federal regulators to look for more enforcement opportunities, say attorneys at Bradley Arant.

  • SEC Crypto Custody Relief Offers Clarity For Funds

    Author Photo

    A recent U.S. Securities and Exchange Commission staff letter supplies a workable path for registered investment advisers and funds seeking to offer crypto custody services by using state trust companies, and may portend additional useful guidance regarding crypto custody, say attorneys at Morgan Lewis.

  • DC Circuit Charts Path On FERC Orders In Loper Bright Era

    Author Photo

    The D.C. Circuit's recent decision in Solar Energy Industries Association v. Federal Energy Regulatory Commission, upholding the agency's assessment of a power production facility's output, laid out an approach for addressing statutory interpretation in FERC appeals in light of the U.S. Supreme Court's game-changing Loper Bright decision, say attorneys at Bracewell.

  • Steps For Healthcare Providers After Cigna ERISA Settlement

    Author Photo

    Following the Cigna class action's settlement, where Employee Retirement Income Security Act violations arose from Cigna's online provider directory advertising providers as in-network who were actually out-of-network, providers should routinely audit their contract status and directory listings, and proactively coordinate with plans and payor partners, say attorneys at ArentFox Schiff.

  • DOJ's UnitedHealth Settlement Highlights New Remedies Tack

    Author Photo

    The use of divestitures and Hart-Scott-Rodino Act compliance in the recent U.S. Department of Justice settlement with UnitedHealth Group and Amedisys underscores the DOJ Antitrust Division's willingness to utilize merger remedies under the second Trump administration, say attorneys at Buchanan Ingersoll.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Compliance archive.